Last updated: June 7, 2026
Solu-Medrol Suppliers: Who Manufactures and Supplies methylprednisolone sodium succinate (Solu-Medrol) for US and global markets
Solu-Medrol is the brand name for methylprednisolone sodium succinate (corticosteroid) supplied as an injectable product. In the absence of product-level sourcing data tied to specific NDC strengths and pack sizes, only market-wide supplier and supply-channel identifiers can be stated reliably: the brand owner, the contract-manufacturing ecosystem, and the typical authorized distribution structure used for injectable hospital products.
Who supplies Solu-Medrol (methylprednisolone sodium succinate) to hospitals in the US?
Featured answer: Solu-Medrol is supplied through authorized pharmaceutical distribution channels in the US (wholesalers and hospital GPO networks), with the product manufactured by the brand sponsor and/or its contract manufacturers and distributed by licensed wholesalers.
What entities typically sit in the supply chain
- Brand sponsor/marketing authorization holder for the US product label (responsible for NDA/BLA-facing obligations and labeling)
- Licensed wholesalers that supply hospitals and group purchasing organizations (GPOs)
- Contract manufacturers producing sterile injectable dosage forms (typically under cGMP and sterile manufacturing compliance)
- Contract packagers and labelers (in some cases, depending on NDC configuration)
What to verify for sourcing
- NDC-specific listing (strength, package size, labeler)
- Distribution authorization status (authorized distributor vs parallel import channel)
- Lot release and sterile batch configuration (sterile manufacturing site)
Which companies manufacture methylprednisolone sodium succinate (Solu-Medrol) injection?
Featured answer: Manufacturing is performed by the labeler/manufacturer listed for the specific NDC, using aseptic sterile manufacturing under cGMP.
Manufacturing site and labeler depend on the NDC
For Solu-Medrol, the same active ingredient can appear under multiple NDCs with different package configurations. Each NDC’s labeler and sometimes manufacturer of record can differ, especially when multiple plants or outsourced sterile fill-finish are used.
Common manufacturing model for sterile injectables
- Drug substance and formulation work under sponsor technical control
- Sterile fill-finish performed in aseptic facilities
- Final drug product batch released under sponsor/contract manufacturer quality systems
How do authorized distributors supply Solu-Medrol to hospitals and GPOs?
Featured answer: US hospital supply is typically routed through major pharmaceutical wholesalers and GPO contracting, with fulfillment based on NDC availability and lot allocations during normal and constrained supply.
Distribution mechanics
- Wholesalers procure from authorized manufacturers and labelers
- GPO contracts price and allocate supply through contracted wholesalers
- Hospitals place orders against NDC-level inventory
What causes procurement friction
- Aseptic sterile production bottlenecks
- Short-cycle stability or packaging constraints
- Lot-specific quality holds that can restrict shipment
Are there generic methylprednisolone sodium succinate suppliers competing with Solu-Medrol?
Featured answer: Yes, generic manufacturers supply methylprednisolone sodium succinate injection products that compete with the brand based on NDC equivalence and availability.
How to identify competing sources
- Compare active ingredient, dosage form, strength, and NDC
- Confirm labeling match (sodium succinate for injection)
- Track FDA-accepted abbreviated application products via Orange Book listings (when needed for substitution analysis)
Which NDCs identify the Solu-Medrol manufacturer and labeler?
Featured answer: The NDC directory entry for each Solu-Medrol strength and package size determines the labeler and manufacturer-of-record for procurement and contracting.
Procurement-ready fields
- Labeler name
- Manufacturer of record
- Package size and dosage strength
- Submission type (useful when mapping to FDA product listing)
What supply constraints or shortages affect Solu-Medrol availability?
Featured answer: For sterile injectable corticosteroids, availability risk is typically driven by sterile fill-finish capacity, raw material supply, and quality batch release rather than patent constraints.
Supply disruption drivers
- Aseptic processing schedule delays
- Visual particulate or container-closure inspection failures
- Secondary packaging or labeling lead times
- Sterile filtration or fill line outages
How does Solu-Medrol supplier selection impact pricing and contracting?
Featured answer: Pricing and contract terms depend on NDC-specific supplier, GPO contracting status, wholesaler inventory, and allocation rules during shortages.
Commercial levers
- Multi-source contracting (multiple labeler/NDC combinations when therapeutically substitutable)
- Lead-time management based on historical lot release patterns
- Back-up distribution channels (secondary wholesaler)
What’s the Orange Book status of Solu-Medrol and how does it affect sourcing?
Featured answer: Orange Book status drives IP-based exclusivity for the reference product and related formulations, but sourcing in procurement is mainly governed by NDC availability and generic entry timelines.
What procurement teams map to
- Reference product identification (brand)
- Approved generic equivalence (ANDA products)
- Formulation or method-of-use differences if they exist across NDCs
Key Takeaways
- Solu-Medrol (methylprednisolone sodium succinate injection) is supplied via authorized US distribution channels to hospitals, with manufacturing performed by the labeler/manufacturer listed for each NDC.
- Supplier identification for procurement is NDC-specific. The correct manufacturer-of-record is determined from the NDC directory entry.
- Generic and alternative sourcing exists for the same active ingredient in injectable form, with substitution governed by NDC equivalence and formulary rules, not just brand name.
- Availability risks for sterile injectables are usually tied to aseptic manufacturing and lot release, not exclusivity.
FAQs
1) Which wholesalers typically distribute Solu-Medrol in the US?
Major pharmaceutical wholesalers distribute Solu-Medrol via authorized channels, routed through hospital and GPO contracting using NDC-level inventory.
2) Can hospitals substitute generic methylprednisolone sodium succinate for Solu-Medrol?
Substitution depends on therapeutic equivalence, NDC match, and formulary policy; generic versions of the same injection category often exist.
3) How do I confirm the manufacturer for a specific Solu-Medrol product?
Use the product’s NDC listing to identify labeler and manufacturer-of-record.
4) What typically causes Solu-Medrol backorders?
Sterile injectable supply interruptions typically stem from aseptic fill-finish capacity constraints, inspection failures, or quality batch release delays.
5) Does FDA exclusivity affect Solu-Medrol sourcing availability?
Exclusivity affects market entry, but in day-to-day procurement the dominant factor is NDC availability from the contracted supplier(s) and wholesalers.
References
- FDA. “NDC Directory.” US Food and Drug Administration.
- FDA. “Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations.” US Food and Drug Administration.
